Cromoglicic acid Completed Phase 3 Trials for Alzheimer's Disease (AD) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02547818 | Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease |